SS Innovations International, Inc. has recently seen a notable transaction involving its CEO, Sudhir Srivastava. On November 10, 2026, Srivastava sold 20,000 shares of the company’s stock. This event is significant as it reflects both a personal and strategic decision within the company, which operates in the surgical and medical instruments sector.
Background
SS Innovations International, Inc. is categorized under the SIC code 3841, which pertains to Surgical & Medical Instruments & Apparatus. The company is publicly traded on the Nasdaq under the ticker SSII. As a smaller reporting company, SS Innovations focuses on providing innovative solutions in the medical field. The company has been active in filing various reports with the SEC, including recent filings on November 13 and October 26, 2026.
What the Filing Says
According to the recent SEC filing (accession number 0001213900-26-120292), Sudhir Srivastava, who serves as both Chairman and CEO, reported the sale of 20,000 shares. The transaction was coded as a disposition of shares, which indicates a strategic move on his part. Following this transaction, Srivastava retains ownership of 108,450,928 shares, held through Sushruta Pvt. Ltd., in which he has a controlling interest.
Impact
This transaction may affect various stakeholders, including investors and market analysts who closely monitor insider trading activities. Such sales can often signal changes in confidence or strategy within a company. For SS Innovations, this move could influence investor sentiment and perceptions of the company’s future direction.
What's Next
The filing does not say what happens next.
Read Next
CTT Pharmaceutical CEO Ryan Khouri Acquires 1,500 Shares
Osisko Gold Grants Incentive Awards to Employees
Sasol Ltd. Reports Recent Activities in SEC Filing
RANGE IMPACT reports third-quarter results for 2026
Energy Co of Parana Updates Executive Board Procedures
Woodcock Alexander reports ownership change in SEC filing








